---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000425"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:23:11.738510+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lipella raises $726k in fourth closing of Series B preferred offering at $2.51 conversion

## Summary
- Gross proceeds of $726,000 from sale of 7,260 Series B shares convertible into 289,241 common shares at $2.51/share.
- Net proceeds of $602,580; Spartan Capital received $123,420 in fees, 84,700 Series C voting preferred shares and warrants for 28,924 common shares.
- CEO Jonathan Kaufman granted irrevocable voting power over Spartan's issued shares via proxy.
- Proceeds from the offering to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001753926-25-000425
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000425/0001753926-25-000425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000425/g084727_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000425
- JSON: https://secwatch.observer/filing/0001753926-25-000425.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.